{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:12:59Z","timestamp":1780463579169,"version":"3.54.1"},"reference-count":97,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:00:00Z","timestamp":1587945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1129391"],"award-info":[{"award-number":["OPP1129391"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Risk Analysis"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Global Polio Eradication Initiative (GPEI) partners engaged modelers during the past nearly 20 years to support strategy and policy discussions and decisions, and to provide estimates of the risks, costs, and benefits of different options for managing the polio endgame. Limited efforts to date provided insights related to the validation of the models used for GPEI strategy and policy decisions. However, modeling results only influenced decisions in some cases, with other factors carrying more weight in many key decisions. In addition, the results from multiple modeling groups do not always agree, which supports selection of some strategies and\/or policies counter to the recommendations from some modelers but not others. This analysis reflects on our modeling, and summarizes our premises and recommendations, the outcomes of these recommendations, and the implications of key limitations of models with respect to polio endgame strategy. We briefly review the current state of the GPEI given epidemiological experience as of early 2020, which includes failure of the GPEI to deliver on the objectives of its 2013\u20132018 strategic plan despite full financial support. Looking ahead, we provide context for why the GPEI strategy of global oral poliovirus vaccine (OPV) cessation to end all cases of poliomyelitis looks infeasible given the current state of the GPEI and the failure to successfully stop all transmission of serotype 2 live polioviruses within four years of the April\u2013May 2016 coordinated cessation of serotype 2 OPV use in routine immunization.<\/jats:p>","DOI":"10.1111\/risa.13484","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T20:20:22Z","timestamp":1588018822000},"page":"229-247","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame"],"prefix":"10.1111","volume":"41","author":[{"given":"Kimberly M.","family":"Thompson","sequence":"first","affiliation":[{"name":"Kid Risk, Inc.  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika A.","family":"Kalkowska","sequence":"additional","affiliation":[{"name":"Kid Risk, Inc.  Orlando FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,4,27]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2013.18.38.20586"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.4.1079"},{"key":"e_1_2_9_4_1","first-page":"35","article-title":"Global eradication of poliomyelitis: Benefit\u2010cost analysis","volume":"74","author":"Bart K.","year":"1996","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00845.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.401"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023290"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1537-8"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1536-9"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3074-0"},{"issue":"5","key":"e_1_2_9_11_1","first-page":"340","article-title":"Maintenance and intensification of bivalent oral poliovirus vaccine use prior to its coordinated global cessation","volume":"7","author":"Duintjer Tebbens R. J.","year":"2016","journal-title":"Journal of Vaccines and Vaccination"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2018-0079"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023938"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-45"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.04.001"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12962"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.026"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12044"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00827.x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2008.01078.x"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12022"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1115-5"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1112-8"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130123"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1465-7"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00842.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.1080.0965"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit838"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1114-6"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2016-0126"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7560.1000339"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816002302"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/2381468317697002"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.090"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1322514"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1506333"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13194"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12560-017-9314-4"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1257\/jep.22.1.67"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92472-4"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu674"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0791-5"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13214"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr399"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit834"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit844"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13193"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13471"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13447"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068284"},{"key":"e_1_2_9_51_1","doi-asserted-by":"crossref","unstructured":"Macklin G. R. O'Reilly K. M. Grassly N. C. Edmunds J. Mach O. Gopala S. \u2026Sutter R. W.(2020).Evolving epidemiology of poliovirus serotype 2 following withdrawal of the type 2 oral 1 poliovirus vaccine.Science. online March 19.https:\/\/doi.org\/10.1126\/science.aba1238","DOI":"10.1126\/science.aba1238"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.276.12.967"},{"issue":"1","key":"e_1_2_9_53_1","first-page":"1","article-title":"Is polio eradication in the Americas economically justified?","volume":"22","author":"Musgrove P.","year":"1988","journal-title":"Bulletin of the Pan American Health Organization"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S189"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.Supplement_1.S165"},{"key":"e_1_2_9_56_1","unstructured":"PTI. (2018).Samples of oral polio vaccine found adulterated: MoS Health. Retrieved fromhttps:\/\/www.newindianexpress.com\/nation\/2018\/dec\/13\/samples-of-oral-polio-vaccine-found-adulterated-mos-health-1910936.html"},{"key":"e_1_2_9_57_1","first-page":"866","volume-title":"Plotkin's vaccines","author":"Sutter R. W.","year":"2017"},{"key":"e_1_2_9_58_1","unstructured":"Thacker T.(2018).Drug regulator forms team to probe polio vaccine lapse case. Retrieved fromhttps:\/\/www.livemint.com\/Politics\/CyBnZJJYUsRnBwa5X3fMEP\/Drug-regulator-forms-team-to-probe-polio-vaccine-lapse-case.html"},{"issue":"4","key":"e_1_2_9_59_1","first-page":"9","article-title":"Valuing prevention as the new paradigm in global health: Managing population immunity for vaccine\u2010preventable diseases","volume":"12","author":"Thompson K. M.","year":"2012","journal-title":"ICU Management"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12030"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60983-1"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00831.x"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60532-7"},{"issue":"8","key":"e_1_2_9_64_1","first-page":"190","article-title":"The case for cooperation in managing and maintaining the end of poliomyelitis: Stockpile needs and coordinated OPV cessation","volume":"10","author":"Thompson K. M.","year":"2008","journal-title":"The Medscape Journal of Medicine"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/sdr.419"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.7551\/mitpress\/9780262016735.003.0009"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.195"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit845"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.864563"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1116-4"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1113-7"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2016-0131"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix128"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix108"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2006.00843.x"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.122192"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.1287\/inte.2014.0769"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1635463"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.013"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1539-6924.2012.01891.x"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/0272-4332.00070"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1177\/003335491212700104"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31279-6"},{"key":"e_1_2_9_84_1","first-page":"841","volume-title":"Plotkin's vaccines","author":"Vidor E.","year":"2017"},{"key":"e_1_2_9_85_1","unstructured":"World Health Assembly. (1988).Global eradication of poliomyelitis by the year 2000 (resolution 41.28). Retrieved fromhttp:\/\/www.who.int\/csr\/ihr\/polioresolution4128en.pdf"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.04.023"},{"key":"e_1_2_9_87_1","unstructured":"World Health Organization. (2016a).Global eradication of wild poliovirus type 2 declared. Retrieved fromhttp:\/\/polioeradication.org\/news-post\/global-eradication-of-wild-poliovirus-type-2-declared\/"},{"key":"e_1_2_9_88_1","unstructured":"World Health Organization. (2016b).The global switch: As it happens. Retrieved fromhttp:\/\/polioeradication.org\/news-post\/the-global-switch-as-it-happens\/"},{"key":"e_1_2_9_89_1","unstructured":"World Health Organization. (2016c).Three years with no wild poliovirus type 3. Retrieved fromhttp:\/\/polioeradication.org\/news-post\/three-years-with-no-wild-poliovirus-type-3\/"},{"issue":"22","key":"e_1_2_9_90_1","first-page":"301","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, April 2017 \u2010 Conclusions and recommendations","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Weekly Epidemiological Record"},{"key":"e_1_2_9_91_1","unstructured":"World Health Organization. (2017b).Report on polio transition planning \u2010 advance draft as of 18 April 2017. Retrieved fromhttp:\/\/www.who.int\/mediacentre\/events\/2017\/advance-report-polio-transmission.pdf?ua=1"},{"key":"e_1_2_9_92_1","unstructured":"World Health Organization. (2019).Two out of three wild poliovirus strains eradicated. Retrieved fromhttps:\/\/www.who.int\/news-room\/feature-stories\/detail\/two-out-of-three-wild-poliovirus-strains-eradicated"},{"key":"e_1_2_9_93_1","unstructured":"World Health Organization. (2020).Polio this week as of 19 February 2020. Retrieved fromhttp:\/\/polioeradication.org\/polio-today\/polio-now\/this-week\/"},{"key":"e_1_2_9_94_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2013).Polio eradication and endgame Strategic Plan (2013\u20102018). Report No: WHO\/POLIO\/13.02 Geneva. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/PEESP_EN_A4.pdf"},{"key":"e_1_2_9_95_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2015).Polio eradication & endgame: Midterm review July 2015. Report No: WHO\/POLIO\/15.04 Geneva. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2016\/07\/GPEI-MTR_July2015.pdf"},{"key":"e_1_2_9_96_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2019).Polio eradication and endgame strategic plan (2019\u20102023). Report No: WHO\/POLIO\/19.04 Geneva. Retrieved fromhttp:\/\/polioeradication.org\/wp-content\/uploads\/2019\/05\/polio-endgame-strategy-2019-2023.pdf"},{"key":"e_1_2_9_97_1","unstructured":"World Health Organization Global Polio Eradication Initiative. (2020).Historical Contributions 1985\u20132019. Retrieved fromhttp:\/\/polioeradication.org\/financing\/donors\/historical-contributions\/"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30113-0"}],"container-title":["Risk Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Frisa.13484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.13484","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/risa.13484","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/risa.13484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:53:58Z","timestamp":1693684438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/risa.13484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,27]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1111\/risa.13484"],"URL":"https:\/\/doi.org\/10.1111\/risa.13484","archive":["Portico"],"relation":{},"ISSN":["0272-4332","1539-6924"],"issn-type":[{"value":"0272-4332","type":"print"},{"value":"1539-6924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,27]]},"assertion":[{"value":"2019-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}